Construction of multifunctional lanthanide-based nanoparticles Ba2LuF7: Yb/Er/Ho for in vivo dual-modal tumor imaging
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Luminescence Properties of Advanced Materials · Nanoplatforms for cancer theranostics · Atomic and Subatomic Physics Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Cancer statistics 2020, CA cancer
2. Three-dimensional angiography fused with CT/MRI for multimodal imaging of nanoparticles based on Ba4Yb3F17: Lu3+, Gd3+10.1039/C8NR03054E ↗
3. A water-soluble, upconverting Sr2Yb0.3Gd0.7F7: Er3+/Tm3+@PSIoAm bio-probe for in vivo trimodality imaging10.1039/C8NR03220C ↗
4. Predicting risk of sudden cardiac death in patients with cardiac sarcoidosis using multimodality imaging and personalized heart modeling in a multivariable classifier
5. ICG-conjugated and 125I-labeled polymeric micelles with high biosafety for multimodality imaging-guided photothermal therapy of tumors10.1002/adhm.201901616 ↗
6. Smart manganese dioxide-based lanthanide nanoprobes for triple-negative breast cancer precise gene synergistic chemodynamic therapy10.1021/acsami.1c08927 ↗
7. Multimodality imaging and artificial intelligence for tumor characterization: current status and future perspective10.1053/j.semnuclmed.2020.07.003 ↗
8. One-pot solventless preparation of PEGylated black phosphorus nanoparticles for photoacoustic imaging and photothermal therapy of cancer10.1016/j.biomaterials.2016.03.022 ↗
9. Core–shell nanostructures: perspectives towards drug delivery applications10.1039/D0TB01559H ↗
10. Multifunctional BaMnLuGdF7: Yb/Er/Ho nanoparticles for in vivo tri-modal imaging10.1016/j.optmat.2020.110578 ↗
11. A water-soluble and upconverting Sr2LaF7: Yb/Er@PSIoAm bio-probe for in vitro/vivo fluorescence imaging10.1016/j.optmat.2020.110652 ↗
12. The photoluminescence mechanism in carbon dots (graphene quantum dots, carbon nanodots, and polymer dots): current state and future perspective10.1007/s12274-014-0644-3 ↗
13. Plasmonic enhancement of the upconversion fluorescence in YVO4: Yb3+, Er3+ nanocrystals based on the porous Ag film10.1016/j.biomaterials.2012.01.063 ↗
14. Stimuli-responsive nanotheranostics based on lanthanide-doped upconversion nanoparticles for cancer imaging and therapy: current advances and future challenges10.1016/j.nantod.2019.02.007 ↗
15. Upconverting nanoparticles10.1002/anie.201005159 ↗
16. Upconversion luminescent materials: advances and applications10.1021/cr400478f ↗
17. Advances in highly doped upconversion nanoparticles10.1038/s41467-018-04813-5 ↗
18. Current advances in lanthanide ion (Ln3+)-based upconversion nanomaterials for drug delivery10.1039/C4CS00155A ↗
19. Lanthanide nanoparticles: from design toward bioimaging and therapy10.1021/acs.chemrev.5b00091 ↗
20. Strategies for constructing upconversion luminescence nanoprobes to improve signal contrast10.1002/smll.201905084 ↗
21. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications10.1038/nrclinonc.2017.44 ↗
22. Synergistic dual-modality in vivo upconversion luminescence/X-ray imaging and tracking of amine-functionalized NaYbF4: Er nanoprobes10.1021/am500383m ↗
23. Metallic nanoparticles as X-Ray computed tomography (CT) contrast agents: a review10.1016/j.molstruc.2020.128599 ↗
24. NaGdF4:Yb3+/Er3+@NaGdF4: Nd3+@Sodium-gluconate: multifunctional and biocompatible ultrasmall core–shell nanohybrids for UCL/MR/CT multimodal imaging10.1021/acsami.5b05194 ↗
25. Multifunctional lanthanide-doped core/shell nanoparticles: integration of upconversion luminescence, temperature sensing, and photothermal conversion properties10.1021/acsomega.7b01581 ↗
26. Hydrothermal synthesis of monodispersed BaGdF5: Yb/Er nanoparticles for CT and MR imaging10.1002/jccs.201600713 ↗
27. Controlled synthesis and upconversion luminescence properties of Yb3+/Er3+ co-doped Bi2O3 nanospheres for optical and X-ray computed tomography imaging10.1016/j.optmat.2020.109827 ↗
28. Colloidally stable P(DMA-AGME)-Ale-coated Gd(Tb)F3: Tb3+(Gd3+), Yb3+, Nd3+ nanoparticles as a multimodal contrast agent for down- and upconversion luminescence, magnetic resonance imaging, and computed tomography10.3390/nano11010230 ↗
29. Bi3+-Doped BaYF5:Yb,Er upconversion nanoparticles with enhanced luminescence and application case for X-ray computed tomography imaging10.1021/acs.inorgchem.0c01818 ↗
30. Assessment of colloidal NaGdF4: Er3+/Yb3+ upconversion phosphor as contrast enhancer for optical coherence tomography10.1016/j.jallcom.2021.158737 ↗
31. Designing stimuli-responsive upconversion nanoparticles that exploit the tumor microenvironment10.1002/adma.202000055 ↗
32. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer10.1039/D0BM00029A ↗
33. Folic acid-modifed diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer10.7150/jca.19786 ↗
34. Folic acid and poly(ethylene glycol) decorated paclitaxel nanocrystals exhibit enhanced stability and breast cancer-targeting capability10.1021/acsami.1c00184 ↗
35. Simultaneous tunable fluorescence lifetime and upconversion luminescence enhancement of NaLuF4: Er3+/Yb3+ microcrystals through heavily doped KF for multiplexing10.1016/j.jlumin.2020.117796 ↗
36. Investigation for the upconversion luminescence and temperature sensing mechanism based on BiPO4: Yb3+, RE3+ (RE3+= Ho3+, Er3+ and Tm3+)10.1016/j.jallcom.2018.09.070 ↗
37. Insight into the temporal response of Yb3+/Tm3+ upconversion luminescence10.1016/j.optcom.2021.127305 ↗
38. Potential urinary monitoring of the enhanced permeability and retention effect using MMP-2-responsive poly(ethylene glycol) derivatives10.1016/j.jconrel.2020.09.004 ↗
39. Addressing delicate and variable cancer morphology in spectral histopathology using canine visceral hemangiosarcoma10.1021/acs.analchem.0c05190 ↗
40. The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists10.1039/C8MT00302E ↗